:

Hui Ye1, Xiaoyu Zou2, Xiangming Fang1

  • 1Department of Anesthesiology and Intensive Care, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China.

PubMed
概括

细胞疗法,特别是仿真抗原受体 (CAR) 免疫细胞疗法,通过调节免疫反应和在外科治疗期间修复器官损伤,显示出治疗败血症的前景.